Secondo Lastoria

Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

Bruno Sangro, L Carpanese, Roberto Cianni et al. · Hepatology · 2011 · 654 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study

Simron Singh, Daniel Halperin, Sten Myrehaug et al. · The Lancet · 2024 · 324 citations · Full text

Medicine, Oncology, Pharmacology +17

Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

Andrea Ciarmiello, Milena Cannella, Secondo Lastoria et al. · PubMed · 2006 · 299 citations

Life Sciences, Neurology, Neuroscience +17

Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases

Maurizio Cosimelli, Rita Golfieri, P P Cagol et al. · British Journal of Cancer · 2010 · 228 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.

Giuseppe Lucio Cascini, Antonio Avallone, Paolo Delrio et al. · PubMed · 2006 · 216 citations

Medicine, Nuclear Medicine, Oncology +17